Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quercus Ilex and Quercus Robur Allergen Extracts. Determination of the in Vivo Allergenic Potency in Histamine Equivalent Units (HEP).

NCT05532566 is registered in ClinicalTrials.gov with Inmunotek S.L. as lead sponsor.

NCT NCT05532566
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05532566 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quercus Ilex and Quercus Robur Allergen Extracts. Determination of the in Vivo Allergenic Potency in Histamine Equivalent Units (HEP).
Lead sponsor
Inmunotek S.L.
Phase
Not applicable
Overall status
Recruiting
Start date
January 24, 2023
Completion date
November 30, 2025
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergic reaction, allergic skin reaction, allergy pollen